(Q53808638)

20 May 2018

title

Free androgen index and Irisin in polycystic ovary syndrome. (English)

1 reference

20 May 2018

polycystic ovary syndrome

main subject

1 reference

1 reference

H Li

1

1 reference

20 May 2018

X Xu

2

1 reference

20 May 2018

X Wang

3

1 reference

20 May 2018

X Liao

4

1 reference

20 May 2018

L Li

5

1 reference

20 May 2018

G Yang

6

1 reference

20 May 2018

L Gao

7

1 reference

20 May 2018

publication date

19 November 2015

1 reference

20 May 2018

Journal of Endocrinological Investigation

published in

1 reference

20 May 2018

volume

39

1 reference

20 May 2018

issue

5

1 reference

20 May 2018

page(s)

549-556

1 reference

20 May 2018

https://scigraph.springernature.com/pub.10.1007/s40618-015-0403-7

exact match

0 references

cites work

Study of carbohydrate metabolism indices and adipocytokine profile and their relationship with androgens in polycystic ovary syndrome after menopause

1 reference

https://api.crossref.org/works/10.1007%2FS40618-015-0403-7

Prevalence and predictors of the metabolic syndrome in women with polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40618-015-0403-7

Mechanisms behind insulin resistance in rat skeletal muscle after oophorectomy and additional testosterone treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40618-015-0403-7

Insulin resistance directly contributes to androgenic potential within ovarian theca cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40618-015-0403-7

Modulation of insulin activities by leptin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40618-015-0403-7

RETRACTED: Visfatin: a protein secreted by visceral fat that mimics the effects of insulin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40618-015-0403-7

Adipocytokines and insulin resistance: the possible role of lipocalin-2, retinol binding protein-4, and adiponectin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40618-015-0403-7

A PGC1-α-dependent myokine that drives brown-fat-like development of white fat and thermogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40618-015-0403-7

Serum irisin levels in new-onset type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40618-015-0403-7

FNDC5 and irisin in humans: I. Predictors of circulating concentrations in serum and plasma and II. mRNA expression and circulating concentrations in response to weight loss and exercise

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40618-015-0403-7

Circulating levels of irisin in patients with anorexia nervosa and different stages of obesity--correlation with body mass index.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40618-015-0403-7

Irisin is expressed and produced by human muscle and adipose tissue in association with obesity and insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40618-015-0403-7

Circulating irisin in relation to insulin resistance and the metabolic syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40618-015-0403-7

Elevated circulating levels of irisin and the effect of metformin treatment in women with polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40618-015-0403-7

Hyperandrogenemia is independently associated with elevated alanine aminotransferase activity in young women with polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40618-015-0403-7

Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40618-015-0403-7

Diagnosis and treatment of polycystic ovary syndrome: an Endocrine Society clinical practice guideline

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40618-015-0403-7

Assessment of insulin sensitivity and beta-cell function from measurements in the fasting state and during an oral glucose tolerance test.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40618-015-0403-7

The use of areas under curves in diabetes research.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40618-015-0403-7

Zinc-finger BED domain-containing 3 (Zbed3) is a novel secreted protein associated with insulin resistance in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40618-015-0403-7

Zinc-α2-glycoprotein is associated with insulin resistance in humans and is regulated by hyperglycemia, hyperinsulinemia, or liraglutide administration: cross-sectional and interventional studies in normal subjects, insulin-resistant subjects, and s

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40618-015-0403-7

Lower circulating irisin is associated with type 2 diabetes mellitus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40618-015-0403-7

Circulating irisin and glucose-dependent insulinotropic peptide are associated with the development of polycystic ovary syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40618-015-0403-7

Polycystic ovary syndrome in adolescence

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40618-015-0403-7

Higher serum testosterone concentration in older women is associated with insulin resistance, metabolic syndrome, and cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40618-015-0403-7

Effects of androgens on insulin action in women: is androgen excess a component of female metabolic syndrome?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40618-015-0403-7

The metabolic syndrome and smoking in relation to hypogonadism in middle-aged men: a prospective cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40618-015-0403-7

Hepatic steatosis is associated with low serum testosterone and high serum DHEAS levels in men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40618-015-0403-7

Endogenous sex hormones and metabolic syndrome in aging men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40618-015-0403-7

Hyperinsulinaemic androgen excess in adolescent girls

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40618-015-0403-7

Metabolic characteristics of women with polycystic ovaries and oligo-amenorrhoea but normal androgen levels: implications for the management of polycystic ovary syndrome.

21 January 2018

1 reference

12 December 2020

A survey of the polycystic ovary syndrome in the Greek island of Lesbos: hormonal and metabolic profile.

1 reference

12 December 2020

Chronic testosterone treatment induces selective insulin resistance in subcutaneous adipocytes of women

1 reference

12 December 2020

4: Polycystic ovary syndrome.

1 reference

12 December 2020

10.1007/S40618-015-0403-7

Identifiers

DOI

1 reference

20 May 2018

PubMed ID

26584566

1 reference

20 May 2018